About this publication

I am Chen Xiao-Yu — 陳曉雨 — an aesthetic editor based between Taipei and Seoul, writing primarily for readers in Hong Kong, Taiwan, and Singapore who track the Korean dermatology corridor more attentively than most. Gangnam Thermage FLX is the dedicated archive I keep on the monopolar-radiofrequency tightening platform that has, over the past three device generations, become a quiet fixture in Cheongdam aesthetic medicine. I started the publication because the conversation around Thermage FLX in our region tends to oscillate between two unhelpful poles — the glossy clinic-side rendering of it as a transformative procedure, and the sceptical Reddit-style dismissal of it as overpriced theatre. Neither, in my reading, is correct. Thermage FLX is a defined modality with a defined clinical lane, a legitimate evidence base for dermal collagen remodelling, and a real role in a sequenced anti-ageing programme. It is also, frankly, easy to misuse — under-shot, over-priced, paired with the wrong adjuncts, sold to the wrong candidate. The editorial work here tries to map that terrain honestly.

Who I am, and where the reading sits

I came up writing aesthetic and skincare coverage for Taiwan's Z-gen lifestyle press before relocating part-time to Seoul in 2024. My beat is observation-led rather than clinical — I am not a physician, and the reading on this publication is editorial, not medical. What I bring to the table is a long period of paying attention: years of consultation transcripts, patient interviews after their second and third Thermage sessions, conversations with Korean coordinators who handle the Hong Kong and Singapore traffic, and the kind of slow accumulation of knowledge that comes from sitting in waiting rooms in Cheongdam at 4pm on a Tuesday. The voice on this site is mine: trend-aware but not breathless, clinical-adjacent but not white-coated, observation-driven rather than recommendation-driven. I write for the reader who has already decided to fly to Seoul and now wants the unvarnished version.

Who operates this publication

Gangnam Thermage FLX is operated by HEIM GLOBAL, a Korea-based medical-tourism facilitator registered with the Korea Health Industry Development Institute under reference A-2026-04-02-06873. HEIM GLOBAL is the commercial parent — it handles the publisher infrastructure, the multilingual coordination, and the editorial commissioning. The reading on this site is mine, the editor's; HEIM GLOBAL does not edit individual entries, although the publication operates within the framework of Korean medical advertising law (article 56 paragraph 4 of the Medical Service Act), which applies to publishers as well as clinics. Some practices featured on this publication maintain commercial referral arrangements with HEIM GLOBAL; where they do, outbound links carry rel="sponsored" and the editorial reading is independent of the commercial relationship. When I cannot reconcile editorial honesty with commercial pressure, I drop the entry. That has happened twice, in case you were wondering.

What this publication covers

The archive is narrow by design. We track Thermage FLX — the current Solta Medical generation — and only Thermage FLX. That includes device specifications across the 900-shot, 1200-shot, and Eyes Total Tip handpieces; comfort pulse and vibration-assist tolerability; protocol design across face, neck, and periocular zones; pricing in KRW with conversions into HKD, SGD, JPY, EUR; aftercare windows for travelling patients; and the consultation framework one ought to bring into the chair before booking. We do not cover Ultherapy PRIME, Sofwave, MFU/HIFU, or other tightening modalities except where comparison with Thermage is unavoidable. Specialised archives elsewhere on the HEIM GLOBAL network handle those. The editorial reasoning for this narrowing is simple: a publication that tries to cover everything covers nothing well, and Thermage FLX deserves a notebook of its own.

Editorial standards, in writing

Three standards run through the publication. First, every clinical claim is sourced — to Solta Medical, to peer-reviewed literature on monopolar radiofrequency dermal heating, to published Korean clinical practice notes, or to the manufacturer's authorised-provider documentation. Where I cannot source a claim, I qualify it. Second, every commercial relationship is disclosed in the page footer, not buried in the terms of service. Third, the publication is revised quarterly — last revision 2026-05-10 — because the platform itself evolves and my reading evolves with it. What the publication does not do: rank clinics, publish #1 lists, or make medical recommendations. The reading is editorial, the decision is the patient's, the procedure belongs to the treating physician. That hierarchy holds throughout.

How to use the archive

Most readers arrive looking for one of three things: an overview of what Thermage FLX is and how it differs from the older NXT generation; a realistic pricing range in their home currency; or a consultation-prep checklist for the first chair-side conversation. Each of those has a dedicated entry — see the [overview](/thermage-flx-overview/), the [pricing piece](/thermage-flx-pricing-korea/), and the [consultation questions guide](/thermage-flx-consultation-questions/). The archive is built for slow reading rather than browsing — there is no infinite scroll, no notification overlay, no popup asking for an email address. If you want to be in touch with HEIM GLOBAL's coordinator team for a live consultation, the Korea Health Industry Development Institute publishes the framework for international medical service in Korea, and HEIM GLOBAL operates within it. The reading itself is free.

Editorial board

This archive is published under the editorial board operated by Gangnam Meditour, a Korea medical-tourism directory registered with KHIDI under A-2026-04-02-06873. Editorial decisions are made by named contributing editors who also write for our specialised treatment archives.

“What separates a useful aesthetic publication from an unhelpful one is whether the editor will say, on the record, that a treatment is wrong for a particular reader.”

Editorial note

Frequently asked questions

Is Chen Xiao-Yu a real editor or a content persona?

I am a working aesthetic editor with a Taiwanese background, writing across Taipei and Seoul. The voice and reading on this publication are mine. HEIM GLOBAL operates the publishing infrastructure; I handle the editorial work. The byline is a real one, not a content marketing persona.

Do clinics pay to be featured on this publication?

Some featured practices maintain commercial referral arrangements with HEIM GLOBAL, the operator. Outbound links to those practices carry rel="sponsored" in the page footer. Editorial inclusion is independent of the commercial relationship — I have dropped entries when the two conflicted, and I will continue to.

Is this publication regulated under Korean medical advertising law?

Yes. The publication operates under article 56 paragraph 4 of the Korean Medical Service Act, which extends advertising restrictions to publishers as well as clinics. We do not publish ranked lists, comparative claims about specific named clinics, or content that would constitute medical advertising under that framework.

How often is the archive revised?

Quarterly. The platform evolves — new tip generations, comfort pulse refinements, pricing shifts in the Gangnam corridor — and my reading evolves with it. The last revision date is in the page footer of every entry. The current revision is 2026-05-10.

Why focus only on Thermage FLX?

Because a publication that tries to cover everything covers nothing well. Thermage FLX has a defined clinical lane, a measurable evolution across device generations, and a steady international patient interest from Hong Kong, Taiwan, Singapore, Japan, and the European Union. It deserves a dedicated notebook rather than a section in a general aesthetics blog.

Can I write to the editor?

Yes — through HEIM GLOBAL's coordinator team, which forwards reader correspondence to me. I read every message, although I do not always reply individually. Corrections, additions, clinical updates, and reader case notes are particularly welcome.

What languages does the publication support?

The primary edition is English. HEIM GLOBAL maintains parallel editions for Traditional Chinese, Simplified Chinese, Japanese, and Spanish on its broader network. Cantonese and Mandarin reader correspondence is welcome and is handled by the coordinator team in the relevant language.

Is the editorial reading available in print?

No. The publication is online-only by design — quarterly revision is incompatible with print cycles, and the international readership is too geographically scattered for a single distribution model to make sense. The web edition is the canonical edition, and it is free.